Roche CEO Thomas Schinecker joins Bloomberg's "The Opening Trade" to discuss his company's earnings and the timeline for the potential launch for Roche's blockbuster breast cancer pill that may become one of the company's biggest sellers by the end of the year.

Moelis Vice Chairman Eric Cantor Talks Energy Independence, Stocks
09:21

Republican Senator Roger Marshall Talks Iran, DHS Funding
08:42

Rivian CEO RJ Scaringe Talks R2 Model
08:44